ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest dr reddys news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks dr reddys across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Dr Reddy's shares fell 9% to Rs 1,080 on the BSE after reporting a weak Q1. Net profit plunged 69% to Rs 443 crore, while revenue dropped 6% to Rs 8,071 crore. The company faced a Rs 240 crore semaglutide API-related impact. Three brokerages slashed target prices.
Summaries by ByteBrief